Trials / Completed

CompletedNCT02576340

Spasmolytic in Upper Gastrointestinal Endoscopy

Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 400 (actual)

Sponsor: Konya Meram State Hospital · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

Upper gastrointestinal system endoscopy is widely used for diagnostic approach. To increase the tolerability and compliance of the patient, sedation is applied. There are many studies showing that sedation increases the patient compliance and the tolerability. However, spasmolytic use in GE has not been evaluated yet.

Conditions

Gastroscopy

Interventions

Type	Name	Description
DRUG	otilonium bromide	otilonium bromide was administered before the procedure

Timeline

Start date: 2013-01-01
Primary completion: 2013-05-01
Completion: 2013-06-01
First posted: 2015-10-15
Last updated: 2015-10-15

Source: ClinicalTrials.gov record NCT02576340. Inclusion in this directory is not an endorsement.